These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 28105695)
1. Bullous lichen planus accompanied by elevation of serum anti-BP180 autoantibody: A possible transitional mechanism to lichen planus pemphigoides. Fujii M; Takahashi I; Honma M; Ishida-Yamamoto A J Dermatol; 2017 Jun; 44(6):e124-e125. PubMed ID: 28105695 [No Abstract] [Full Text] [Related]
2. Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering. Hübner F; Langan EA; Recke A Front Immunol; 2019; 10():1389. PubMed ID: 31312198 [TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. Zillikens D; Caux F; Mascaro JM; Wesselmann U; Schmidt E; Prost C; Callen JP; Bröcker EB; Diaz LA; Giudice GJ J Invest Dermatol; 1999 Jul; 113(1):117-21. PubMed ID: 10417629 [TBL] [Abstract][Full Text] [Related]
5. A case of lichen planus pemphigoides with autoantibodies to the NC16a and C-terminal domains of BP180 and to desmoglein-1. Sekiya A; Kodera M; Yamaoka T; Iwata Y; Usuda T; Ohzono A; Yasukochi A; Koga H; Ishii N; Hashimoto T Br J Dermatol; 2014 Nov; 171(5):1230-5. PubMed ID: 24813536 [TBL] [Abstract][Full Text] [Related]
6. Atezolizumab-induced lichen planus pemphigoides in a patient with metastatic non-small-cell lung cancer. Senoo H; Kawakami Y; Yokoyama E; Yamasaki O; Morizane S J Dermatol; 2020 Apr; 47(4):e121-e122. PubMed ID: 31984550 [No Abstract] [Full Text] [Related]
7. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180. Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407 [TBL] [Abstract][Full Text] [Related]
8. Atypical subacute cutaneous lupus erythematosus presenting as lichen planus pemphigoides with autoantibodies to C-terminus of BP180, desmoglein 1 and SS-A/Ro antigen. Inoue Y; Adachi A; Ueno M; Fukumoto T; Nishitani N; Fujiwara N; Yamada Y; Ohyama B; Tsuruta D; Hashimoto T J Dermatol; 2012 Nov; 39(11):960-2. PubMed ID: 22413755 [No Abstract] [Full Text] [Related]
10. Lichen planus pemphigoides with IgG autoantibodies to the 180 kd bullous pemphigoid antigen (type XVII collagen). Hsu S; Ghohestani RF; Uitto J J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):136-41. PubMed ID: 10607335 [TBL] [Abstract][Full Text] [Related]
11. Lichen planus pemphigoides developing from patient with non-small-cell lung cancer treated with nivolumab. Sato Y; Fujimura T; Mizuashi M; Aiba S J Dermatol; 2019 Oct; 46(10):e374-e375. PubMed ID: 31062404 [No Abstract] [Full Text] [Related]
12. Lichen planus pemphigoides with circulating autoantibodies against 200 and 180 kDa epidermal antigens. Yoon KH; Kim SC; Kang DS; Lee IJ Eur J Dermatol; 2000; 10(3):212-4. PubMed ID: 10725820 [TBL] [Abstract][Full Text] [Related]
16. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid. Bing L; Xiping Z; Li L; Jun P; Yi-Xia W; Min Y; Qing L; Qiu-Ning S; Hong-Zhong J; Ya-Gang Z Arch Dermatol Res; 2015 Nov; 307(9):849-54. PubMed ID: 26404084 [TBL] [Abstract][Full Text] [Related]
17. Childhood lichen planus pemphigoides: a case report and review of the literature. Cohen DM; Ben-Amitai D; Feinmesser M; Zvulunov A Pediatr Dermatol; 2009; 26(5):569-74. PubMed ID: 19840313 [TBL] [Abstract][Full Text] [Related]